ApprovalTrail

Drug · DIN 02280019

BISMUTH CAPLETS

Authorized, not yet reported as sold

Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.

Status Approved since January 22, 2008.
Drug Identification Number (DIN)
02280019
Company (DIN owner)
Tanta Pharmaceuticals IncWhitby, Ontario, Canada
Schedule
Non-prescription drugs
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Bismuth preparations A07BB
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
BISMUTH SUBSALICYLATE262 MG

Other DINs named BISMUTH CAPLETS